(VIANEWS) – The NASDAQ opens in less than six hours and Xenetic Biosciences‘s pre-market value is already 5.63% up.

The last session, NASDAQ Composite finished with Xenetic Biosciences (XBIO) falling 8.39% to $1.42. NASDAQ Composite rose 0.45% to $15,993.71, following the last session’s upward trend on what was a somewhat positive trend exchanging session.


Today’s last reported volume for Xenetic Biosciences is 335863, 47.53% below its average volume of 640176.

Xenetic Biosciences’s last close was $1.55, 73.5% below its 52-week high of $5.85.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the current quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $1.42 at 04:28 EST, way below its 52-week high of $5.85 and way higher than its 52-week low of $0.82.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s worth is way below its 50-day moving average of $1.86 and way under its 200-day moving average of $2.29.


Xenetic Biosciences’s last day, last week, and last month’s current intraday variation average was 4.52%, 2.73%, and 1.95%, respectively.

Xenetic Biosciences’s highest amplitude of average volatility was 7.04% (day), 4.55% (last week), and 4.99% (last month), respectively.

More news about Xenetic Biosciences (XBIO).


Please enter your comment!
Please enter your name here